Product Name (品名): |
1,3-Bis(1-methylethyl)-2-thioxo-4,5-imidazolidinedione 1,3-双(1-甲基乙基)-2-硫代-4,5-咪唑二酮 |
| Appearance(外观): | Yellow powder |
Molecular Formula (分子式): |
C9H14N2O2S
|
Molecular Weight (分子量): | 214.29 |
Purity (纯度): | 98% |
| Production Capacity (产能) | 3000KG/ Year |
Specification:(指标) | MS, HNMR, Purity 98%
|
Contact Telephone (联系电话): | 023-677770219 |
Contact | Sales Department |
| Contact Email: | sales@chemieliva.com |
用途 有机合成中的关键中间体与辅助试剂 构建复杂杂环衍生物:该物质含有的硫代咪唑烷二酮骨架是杂环合成的重要模块,环上的硫代羰基等官能团易发生衍生化反应。例如它可与胺类、酰氯类化合物反应,或参与碳 - 硫键构建相关反应,用于合成结构更复杂的杂环化合物,为精细化学品、特种材料的合成提供基础结构单元。且有研究显示该类化合物可通过简便的一锅法合成,能作为高效合成其他硫代咪唑烷二酮类物质的参考模板。 潜在手性合成助剂:其分子结构中的咪唑烷环易修饰形成手性中心,而同类含异丙基的硫代杂环化合物(如 (S)-4 - 异丙基噻唑烷 - 2 - 硫)常作为高选择性手性助剂,可通过还原裂解等反应辅助目标产物的结构构建。由此推测,该物质经结构优化后,有望在不对称合成中辅助构建手性结构,助力合成具有特定立体构型的有机中间体。
生物医药研发的潜力原料 多类抗菌抗病毒药物前体:2 - 硫代咪唑烷 - 4,5 - 二酮类化合物是公认的高效抗菌、抗病毒活性骨架,这类物质可用于研发抗结核、抗疱疹等药物。该物质可作为这类药物的合成起点,通过取代基修饰优化药理活性,为开发新型抗菌抗病毒候选药物提供结构基础。 抗肿瘤与抗炎药物研发方向:相关研究表明,咪唑烷二酮类衍生物具备抗肿瘤、抗炎等药理活性,部分该类化合物还被开发为组蛋白去乙酰化酶抑制剂,用于神经退行性疾病和癌症的研究。该物质可依托自身核心骨架,经结构改造后探索其在抗肿瘤、抗炎领域的应用潜力,为相关疾病的新型药物研发提供参考。 其他药用活性探索:除上述方向外,该类硫代杂环化合物还被证实具有降血脂、抗溃疡等潜在活性。该物质可作为研究样本,用于筛选这类药用活性,为心血管疾病、消化系统疾病等相关药物的研发提供新思路。
Function Key intermediate and auxiliary reagent in organic synthesis Construction of complex heterocyclic derivatives: The thioimidazolidinedione skeleton serves as a critical module for heterocycle synthesis. Functional groups such as the thiocarbonyl group on the ring readily undergo derivatization reactions (e.g., reactions with amines or acid chlorides, or carbon-sulfur bond formation reactions), enabling the synthesis of more complex heterocyclic compounds. These compounds provide basic structural units for the synthesis of fine chemicals and specialty materials. Potential chiral auxiliary: The imidazolidine ring in its molecular structure can be easily modified to form a chiral center. Similar isopropyl-containing thioheterocyclic compounds (e.g., (S)-4-isopropylthiazolidine-2-thione) are often used as highly selective chiral auxiliaries, which can assist in the structural construction of target products through reactions such as reductive cleavage. Thus, this substance is expected to assist in the construction of chiral structures in asymmetric synthesis after structural optimization, facilitating the synthesis of organic intermediates with specific stereoconfigurations.
Potential raw material for biomedical R&D Precursor for multiple antibacterial and antiviral drugs: Thioimidazolidinedione derivatives are recognized as highly effective antibacterial and antiviral active skeletons, which can be used in the R&D of anti-tuberculosis and anti-herpes drugs. This substance can serve as a starting point for the synthesis of such drugs, and its pharmacological activity can be optimized through substituent modification, providing a structural basis for the development of novel antibacterial and antiviral candidate drugs. R&D direction for anti-tumor and anti-inflammatory drugs: Relevant studies have shown that imidazolidinedione derivatives exhibit anti-tumor, anti-inflammatory and other pharmacological activities. Some of these compounds have also been developed as histone deacetylase inhibitors for the research of neurodegenerative diseases and cancer. Relying on its core skeleton, this substance can explore its application potential in the field of anti-tumor and anti-inflammatory through structural modification, providing references for the R&D of novel drugs for related diseases. Exploration of other pharmaceutical activities: In addition to the above directions, such thioheterocyclic compounds have also been proven to have potential activities such as lipid-lowering and anti-ulcer. This substance can be used as a research sample to screen for such pharmaceutical activities, providing new ideas for the R&D of drugs related to cardiovascular diseases, digestive system diseases, etc.
|
Structure (结构式):

|
1,3-Bis(1-methylethyl)-2-thioxo-4,5-imidazolidinedione
1,3-双(1-甲基乙基)-2-硫代-4,5-咪唑二酮
24092-21-5 ||Chemieliva Pharmaceutical Co., Ltd || 重庆福腾医药|| 24092-21-5 seller || 24092-21-5 supplier || 24092-21-5 manufacturer || 24092-21-5 producer || 24092-21-5 price || 24092-21-5 China || 24092-21-5 India || 24092-21-5 MSDS || 24092-21-5 COA || CAS 24092-21-5 || buy 24092-21-5 || 24092-21-5 offer || 24092-21-5 seller || sell 24092-21-5 || selling 24092-21-5 || 24092-21-5 factory || 24092-21-5 factory || 24092-21-5 data || China 24092-21-5 || 24092-21-5 export ||

Canonical SMILES
O=C1C(=O)N(C(=S)N1C(C)C)C(C)C
InChI
InChI=1S/C9H14N2O2S/c1-5(2)10-7(12)8(13)11(6(3)4)9(10)14/h5-6H,1-4H3
InChI Key
JQUADKJZYNERDX-UHFFFAOYSA-N
5 Other Names for this Substance
1,3-Bis(1-methylethyl)-2-thioxo-4,5-imidazolidinedione (ACI)
Imidazolidinetrione, 1,3-diisopropyl-2-thio- (7CI, 8CI)
1,3-Diisopropyl-2-thioimidazolidinetrione
1,3-Diisopropyl-4,5-dioxo-imidazoline-2-thione
1,3-Diisopropyl-4,5-dioxoimidazolidine-2-thione
++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++
Other products recommendation:
Product Name:2-(4-bromophenyl)-Bicyclo[2.2.1]heptane
中文名:2-(4-溴苯基)双环[2.2.1]庚烷
CAS: 2533349-57-2
Product link: https://www.chemieliva.com/product_content-25-15673666.html?CASNo=2533349-57-2
Supplying Capacity: 3000KG/Year
Structure:

Product Name: 4-Cyclohexylaniline
中文名:4-环己苯胺
CAS: 6373-50-8
Product link: https://www.chemieliva.com/product_content-25-15673667.html?CASNo=6373-50-8
Supplying Capacity: 3000KG/Year
Structure:

Product Name:4-(Bicyclo[2.2.1]Heptan-2-yl)-N-(4-Cyclohexylphenyl)Aniline
中文名:4-二环[2.2.1]庚-2-基-N-(4-环己基苯基)-苯胺
CAS: 2957917-99-4
Product link: https://www.chemieliva.com/product_content-25-15673668.html?CASNo=2957917-99-4
Supplying Capacity: 3000KG/Year
Structure:

